Search
About WifOR
Research
Health
Burden of Disease
Health Economy Reporting
Health ROI Assessor
Social Impact
Sustainability
Economic and R&D Footprint
Environmental Footprint
Impact Valuation
Benchmarks
Value Factors
Scope 3 Assessment
Social Hotspot Analysis
WISIT – the WifOR Institute Sustainability Impact Tool
Labor Market
Big Data Skills Analysis
Employer Attractiveness Analysis
Diversity, Equity & Inclusion
Diversity study
Skilled Labor Analysis
Data packages
GHG Emission Factors
Spend-based Multipliers for Sustainability Analysis
Value Factors
Publications
Newsroom
Career
DE
EN
Contact
Latest publications
Journal publication
Prof. Rifat Atun, Dr. Jan Ludwig Fries, Dr. Karla Hernandez-Villafuerte, Dr. Malina Müller, Prof. Dennis Ostwald, Dr. Maike Schmitt
04/2025
Contribution of investment in health and cancer control to economic growth in Commonwealth countries
Method paper
Dr. Richard Scholz, Dr. Nora Albu, Dr. Daniel Croner, Dr. Zarko Kalamov, Lukas Mai, Dr. Silvia Forin, Jasmin Tesch, Tabea Dorndorf, Jana Setzer
03/2025
WifOR Impact Valuation
Study
Davide Lovera, Dr. Jasper Ubels
06/2025
The Socioeconomic Burden of Migraine: The Case of 6 European Countries
Library
Research area
Career
Health
Labor Market
Newsletter
Sustainability
Publication type
Conference poster
Journal publication
Method paper
Scientific article
Study
Method paper
2024
The Value of Investing in Innovative Medicines: Socioeconomic Burden and Annual Social Impact of Roche Treatments for HER2+ Breast Cancer, Multiple Sclerosis and Retinal Disease
Adnan Atitallah, Jennifer Branner, Prof. Dennis A. Ostwald, Dr. Rebecca Grün, Dr. Maren Herrlitz, Dr. Eva Levi, Davide Lovera, Dr. Malina Müller, Dr. Platon Peristeris, Lena Steinbeck, Gabriele Filkauskas, Katya Galactionova, Khaled Ismail, Svenn Alexander Kommandantvold, Kopano Mukelabai, Thomas Paling, Kunal Samanta, Charlie Smith, Simone Sutherland, Andrew Walker
Study
2024
The Value of Investing in Innovative Medicines: Socioeconomic Burden and Annual Social Impact of Roche Treatments for HER2+ Breast Cancer, Multiple Sclerosis and Retinal Disease
Adnan Atitallah, Jennifer Branner, Prof. Dennis A. Ostwald, Dr. Rebecca Grün, Dr. Maren Herrlitz, Dr. Eva Levi, Davide Lovera, Dr. Malina Müller, Dr. Platon Peristeris, Lena Steinbeck
Method paper
2024
WifOR Impact Valuation
Dr. Richard Scholz, Dr. Nora Albu, Dr. Daniel Croner, Dr. Zarko Kalamov, Lukas Mai, Dr. Silvia Forin, Jasmin Tesch, Tabea Dorndorf, Jana Setzer
Journal publication
2024
Does the Vaccination against Tick-Borne Encephalitis Offer Good Value for Money for Incidence Rates below the WHO Threshold for Endemicity? A Case Study for Germany
Dr. Malina Müller, Hannah Lintener, Vivien Henkel, Andreas Pilz, Kate Halsby, Claudius Malerczyk, Harish Madhava, Jennifer C. Moïsi, Holly Yu, Katharina Schley
Journal publication
2024
Radiotherapy and theranostics: a Lancet Oncology Commission
May Abdel-Wahab, Francesco Giammarile, Mauro Carrara, et al.
Journal publication
2024
Collaboration for new therapies: maximizing health and innovation
Jorge Mestre-Ferrandiz, Pierre Meulien, Prof. Dr. Dennis Ostwald, Virginia Acha
‹
1
2
3
4
5
…
16
›
Interested in our newsletter?
Register
Bewertungsfaktoren 1.0 von WifOR Institute
Version Juli 2023
Download
